Gene therapy marks a turning point for rare skin diseases
Gene therapy marks a turning point for rare skin diseases Summary A gel-based gene therapy (beremagene geperpavec, marketed as Vyjuvek/B-VEC) and a graft-delivered gene therapy (prademagene zamikeracel, marketed as Zevaskyn/pz-cel)…
